Correlation of gut microbiota with leukopenia after chemotherapy in patients with colorectal cancer

From BugSigDB
Needs review
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Xiaofeng N, Jian C, Jingjing W, Zhanbo Q, Yifei S, Jing Z, Shuwen H
Journal
BMC microbiology
Year
2023
Keywords:
Chemotherapy, Colorectal cancer, Gut microbiota, Leukopenia, Myelosuppression
BACKGROUND: The most common toxic side effect after chemotherapy, one of the main treatments for colorectal cancer (CRC), is myelosuppression. OBJECTIVE: To analyze the correlation between gut microbiota and leukopenia after chemotherapy in CRC patients. METHODS: Stool samples were collected from 56 healthy individuals and 55 CRC patients. According to the leukocytes levels in peripheral blood, the CRC patients were divided into hypoleukocytes group (n = 13) and normal leukocytes group (n = 42). Shannon index, Simpson index, Ace index, Chao index and Coverage index were used to analyze the diversity of gut microbiota. LDA and Student's t-test(St test) were used for analysis of differences. Six machine learning algorithms, including logistic regression (LR) algorithm, random forest (RF) algorithm, neural network (NN) algorithm, support vector machine (SVM) algorithm, catboost algorithm and gradient boosting tree algorithm, were used to construct the prediction model of gut microbiota with leukopenia after chemotherapy for CRC. RESULTS: Compared with healthy group, the microbiota alpha diversity of CRC patients was significantly decreased (p < 0.05). After analyzing the gut microbiota differences of the two groups, 15 differential bacteria, such as Bacteroides, Faecalibacterium and Streptococcus, were screened. RF prediction model had the highest accuracy, and the gut microbiota with the highest predictive value were Peptostreptococcus, Faecalibacterium, and norank_f__Ruminococcaceae, respectively. Compared with normal leukocytes group, the microbiota alpha diversity of hypoleukocytes group was significantly decreased (p < 0.05). The proportion of Escherichia-Shigella was significantly decreased in the hypoleukocytes group. After analyzing the gut microbiota differences of the two groups, 9 differential bacteria, such as Escherichia-Shigella, Fusicatenibacter and Cetobacterium, were screened. RF prediction model had the highest accuracy, and the gut microbiota with the highest predictive value were Fusicatenibacte, Cetobacterium, and Paraeggerthella. CONCLUSION: Gut microbiota is related to leukopenia after chemotherapy. The gut microbiota may provide a novel method for predicting myelosuppression after chemotherapy in CRC patients.

Experiment 1


Needs review

Curated date: 2024/03/20

Curator: Ayibatari

Revision editor(s): Ayibatari

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Colorectal carcinoma cancer of large bowel,cancer of large intestine,cancer of the large bowel,cancer of the large intestine,carcinoma of colorectum,carcinoma of large bowel,carcinoma of large intestine,carcinoma of the large bowel,carcinoma of the large intestine,colorectal (colon or rectal) cancer,colorectal cancer,colorectal carcinoma,colorectum carcinoma,CRC,large bowel cancer,large bowel carcinoma,large intestine cancer,large intestine carcinoma,Colorectal carcinoma
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy
Group 1 name Corresponds to the case (exposed) group for case-control studies
Colorectal cancer (CRC)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients who has colorectal cancer (CRC)
Group 0 sample size Number of subjects in the control (unexposed) group
56
Group 1 sample size Number of subjects in the case (exposed) group
55

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Kruskall-Wallis
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.00

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged
Richness Number of species
unchanged

Signature 1

Needs review

Curated date: 2024/03/20

Curator: Ayibatari

Revision editor(s): Ayibatari

Source: Figure 2 B.

Description: LDA was used to draw histograms and count the gut microbiota with significant differences between the two groups. LDA scores were obtained using linear regression analysis. The greater the score, the greater the influence of gut microbiota abundance on differential effects.

Abundance in Group 1: increased abundance in Colorectal cancer (CRC)

NCBI Quality ControlLinks
Acinetobacter
Actinomyces
Aeromonas
Aggregatibacter
Akkermansia
Alloscardovia
Anaeroglobus
Aquabacterium
Arthrobacter
Bradyrhizobium
Brevundimonas
Butyricimonas
Christensenella
Corynebacterium
Eikenella
Enterobacter
Enterococcus
Exiguobacterium
Fretibacterium
Gemella
Granulicatella
Klebsiella
Lachnoclostridium
Lactobacillus
Megamonas
Mitsuokella
Mogibacterium
Morganella
Olsenella
Parabacteroides
Parvimonas
Peptostreptococcus
Propionibacterium
Pseudoramibacter
Ralstonia
Raoultella
Rhodococcus
Scardovia
Selenomonas
Slackia
Solobacterium
Sphingomonas
Streptococcus
unclassified Comamonadaceae
unclassified Coriobacteriales
unclassified Enterobacteriaceae
unclassified Lactobacillales
Burkholderia-Caballeronia-ParaburkholderiaBurkholderia-Caballeronia-Paraburkholderia
Coriobacteriaceae_UCG-002Coriobacteriaceae_UCG-002
Prevotellaceae_UCG-001Prevotellaceae_UCG-001

Revision editor(s): Ayibatari

Experiment 2


Needs review

Curated date: 2024/03/20

Curator: Ayibatari

Revision editor(s): Ayibatari

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
normal leukocytes
Group 1 name Corresponds to the case (exposed) group for case-control studies
hypoleukocytes
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients in this group have lower-than-normal levels of leukocytes in their blood.
Group 0 sample size Number of subjects in the control (unexposed) group
42
Group 1 sample size Number of subjects in the case (exposed) group
13

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged
Richness Number of species
unchanged

Signature 1

Needs review

Curated date: 2024/03/20

Curator: Ayibatari

Revision editor(s): Ayibatari

Source: Fig. 6 B

Description: LDA was used to draw histograms and count the gut microbiota with significant differences between the two groups. LDA scores were obtained using linear regression analysis. The greater the score, the greater the influence of gut microbiota abundance on differential effects.

Abundance in Group 1: increased abundance in hypoleukocytes

NCBI Quality ControlLinks
Cetobacterium
Eggerthella
Granulicatella
Coriobacteriaceae_UCG-002Coriobacteriaceae_UCG-002
unclassified Candidatus Saccharibacteria

Revision editor(s): Ayibatari

Signature 2

Needs review

Curated date: 2024/03/20

Curator: Ayibatari

Revision editor(s): Ayibatari

Source: Figure 6 B.

Description: LDA was used to draw histograms and count the gut microbiota with significant differences between the two groups. LDA scores were obtained using linear regression analysis. The greater the score, the greater the influence of gut microbiota abundance on differential effects.

Abundance in Group 1: decreased abundance in hypoleukocytes

NCBI Quality ControlLinks
Christensenella
Coprobacillus
Enorma
Escherichia/Shigella sp.
Eubacterium ruminantium
Fusobacterium
Klebsiella
Megamonas
Oscillibacter
Paludicola
Paraclostridium
Phascolarctobacterium
Tyzzerella
unclassified Oscillospiraceae
Ruminococcus torques groupRuminococcus torques group
Erysipelotrichaceae UCG-003Erysipelotrichaceae UCG-003
Ezakiella

Revision editor(s): Ayibatari